CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $411,605
- in 5 filings
Net −$411,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-13 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (Right to Buy) | +47,745 | 47,745 | ||
| 2022-06-13 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +47,745 | 47,745 | ||
| 2022-05-19 | RTW INVESTMENTS, LP 10% owner | Other acquisition · Equity Swap (obligation to buy) | +1 | 1,000,000 | ||
| 2022-04-18 | Militello John | Other acquisition | +7,932 | 32,352 | ||
| 2022-04-18 | Militello John | Other acquisition · Restricted Stock Units | +7,932 | 0 | ||
| 2022-04-18 | Militello John | Grant or award · Stock Option (Right to Buy) | +28,910 | 28,910 | ||
| 2022-04-18 | Militello John | Grant or award · Restricted Stock Units | +19,054 | 19,054 | ||
| 2022-04-01 | Schwartz Jonathan David | Sale | −12,974 | $15.86 | $206K | 121,555 |
| 2022-04-01 | Schwartz Jonathan David | Sale | −32,026 | $16.20 | $519K | 89,529 |
| 2022-03-31 | Schwartz Jonathan David | Sale | −9,002 | $15.90 | $143K | 170,527 |
| 2022-03-31 | Schwartz Jonathan David | Sale | −35,998 | $16.15 | $581K | 134,529 |
| 2022-03-30 | Schwartz Jonathan David | Sale | −10,562 | $15.94 | $168K | 213,967 |
| 2022-03-30 | Schwartz Jonathan David | Sale | −34,438 | $16.56 | $570K | 179,529 |
| 2022-03-30 | Schwartz Jonathan David | Sale | −10,562 | $15.94 | $168K | 213,967 |
| 2022-03-30 | Schwartz Jonathan David | Sale | −34,438 | $16.56 | $570K | 179,529 |
| 2022-03-10 | Malik Fady Ibraham Director | Grant or award · Stock Option (Right to Buy) | +33,199 | 33,199 | ||
| 2022-03-10 | Malik Fady Ibraham Director | Grant or award · Stock Option (Right to Buy) | +8,641 | 8,641 | ||
| 2022-02-14 | Shah Gaurav CEO | Other acquisition | +23,940 | 670,074 | ||
| 2022-02-14 | Shah Gaurav CEO | Other disposition · Restricted Stock Units | −23,940 | 0 | ||
| 2022-02-14 | Patel Kinnari | Other acquisition | +11,970 | 313,794 |
Page 20 of 27 · 538 trades